Viral Antigens Market
Viral Antigens Market By Component (Influenza, Coronavirus, Zika Virus, Ebola Virus, Dengue Virus, Rotavirus Viral & Epstein-Barr Virus Antigens, Others), By Technique, By End-User, By Region - Global Mraket Forecast 2020-2030
Viral Antigens Market Insights: Advancement in Image Analysis and Improvised Informatics Solutions to Boost Growth
Adoption of viral antigens in vaccine development by clinicians and researchers has been increasing on a significant pace. Advancements in image analysis software and informatics platforms for viral antigen detection are driving the vaccine development research, which is expected to fuel the viral antigens market growth over the forecast period (2020-2025).
Most of the recently developed techniques such as Electron Microscopy workflow are promising for advancement in viral research. For example, with development in image systems, it is possible to capture image in real time and produce immunoassay results which are efficient and reproducible. Frequent outbreaks of infectious diseases caused by viruses, such as influenza, hepatitis, AIDS, and recently COVID-19, are creating urgency in the vaccine research and development. The result is expected to lead to rapid growth of the viral antigens market.
The usage of viral antigens will be further driven by development of multiple imaging modes. With rapid advancement in both science and technology, it has become possible to capture both picture and videos of viral antigens immunogenicity analysis in HD mode.
Advanced automated tools have also been developed that capture high quality HD images in different phases and present reproducible images both in red and green fluorescent contrasting forms, for differential cell analysis. Using, differential objectives on an automated turret, the devices can be used to address a variety of parallel applications.
Avail customized purchase options for your needs
Viral Antigens Market Analysis by Technique: ELISA Remains Highly Preferred
ELISAs are widely used as an effective tool in the detection and diagnosis of virus infection. These immunoassays are garnering momentum as safe, specific, and rapid, owing to the ability to produce recombinant viral proteins. Adoption of ELISA for identifying viral antigens is expected to account for major share of the stakeholders’ bottom lines and increase at a significant CAGR of 8.2% during the forecast period.
Electron microscopy is rapid emerging as a powerful technique to identify viral antigens and determine their structural organization and localization within viruses and vaccines. With greater awareness of electron microscopy among professionals in vaccine research, market stakeholders are directing their focus to this category. Adoption of electron microscopy is projected at a solid 9.4% CAGR through 2025.
Viral Antigens Market: Competition Analysis
Technological advancements in biopharmaceutical industry are offering significant growth opportunities for players in the viral antigens market, leading to the launch of new and advanced products.
Moreover, increase in the product development and new launches, including the launch of several novel recombinant antigens for the development of antibody tests for COVID-19 will further accelerate the expansion of the viral antigens market.
For instance, in 2020, Creative Diagnostics launched new immunoassay kits for direct detection of the new coronavirus and antibodies against SARS-CoV-2. Later, The Native Antigen Company and OXGENE signed a mutual agreement to increase production of COVID-19 antigens for manufacturing diagnostic kits and vaccine development and supporting more researchers in their critical work.
An Adaptive Approach to Modern-day Research Needs
COVID-19 Impact Analysis
Increasing demand for viral antigens in COVID-19 vaccine development and diagnostic kits is expected to propel growth of the global viral antigens market. According to the WHO, currently there are more than 2 million active coronavirus cases worldwide, which are initiating the adoption of viral recombinant antigens that are capable of producing recombinant viral proteins.
Increasing cases of coronavirus have significantly led to a spike in demand for COVID-19 antibody detection kits focused towards prevention, early detection and monitoring of the disease. Moreover, growing incidence of acute diseases such as cancers, AIDS, hepatitis & infectious diseases is influencing the use of the high competency of viral antigens to reduce the risk of such diseases.
“The advent of technologically advanced vaccine research platforms and increase R&D activities in viral proteins remain major growth drivers of the viral antigens market. Significant efforts to develop rapid diagnostic kits and vaccines for the novel coronavirus will also uplift growth prospects of the market”.
Interested to Procure The Data
Viral Antigens Market: Report Scope
The recent study on viral antigens market by Fact.MR incorporates a five-year forecast period from 2020 to 2025 and explicates on vital dynamics such as the key drivers, opportunities and restraints impacting the market growth.
The report provides an in-depth study concerning the revenue, market share and year-on-year growth across the following segments: component type, technique, and end user.
In addition, a regional landscape incorporating the above mentioned segments has been embedded within the report. Regional analysis is done based on the following geographies: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
In the final section, a competitive landscape providing information on the prominent market players, their revenue, market share, collaborations and product launches has been included.
Key Segments of Viral Antigens Market
Fact.MR’s study on the viral antigens market offers information divided into three important segments-component, technique,end-user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
By Component :
- Influenza Viral Antigens
- Coronavirus Antigens
- Zika Virus Antigens
- Ebola Virus Antigens
- Dengue Virus Antigens
- Herpes Simplex Virus (HSV) Viral Antigens
- Rotavirus Viral Antigens
- Epstein-Barr Virus Antigens
- Hepatitis A-E Virus Antigens
- Parainfluenza Virus Antigens
- Measles Virus Antigens
- Adenovirus Viral Antigens
- Mumps/Parotitis Virus Antigens
- Varicella Zoster Virus (VZV) Antigens
By Technique :
- Radioimmunoassay (RIA)
- Immunoperoxidase Staining
- Electron Microscopy
By End-User :
- Diagnostic Centers
- Blood Banks
- Research Institutes
By Region :
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
- FAQs -
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.